February 17, 2022
Targovax ASA: Fourth quarter 2021 results
Media
February 14, 2022
Invitation to presentation of 2021 year-end results
February 10, 2022
BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for year end report 2021
February 10, 2022
Vicore’s AIR study interim analysis suggests that C21 improves lung function in IPF patients
February 09, 2022
Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 09, 2022
Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February
February 04, 2022
Hemab Therapeutics Announces First Drug Candidate: HMB-001, a Novel Bispecific Antibody with Potential for Treatment of Rare Bleeding Disorders
February 01, 2022
Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden
February 01, 2022
Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration
January 31, 2022
Xeris Biopharma Announces Recorlev® (levoketoconazole) Is Now Commercially Available for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome